PMC:7228307 / 1304-1526 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"19","span":{"begin":81,"end":85},"obj":"Gene"}],"attributes":[{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ed and novel mAbs. A more mature appreciation of the immunobiology of individual FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” thera"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T14","span":{"begin":19,"end":20},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T15","span":{"begin":81,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T16","span":{"begin":143,"end":145},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T17","span":{"begin":146,"end":148},"obj":"http://purl.obolibrary.org/obo/CLO_0008882"}],"text":"ed and novel mAbs. A more mature appreciation of the immunobiology of individual FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” thera"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T8","span":{"begin":86,"end":94},"obj":"http://purl.obolibrary.org/obo/BFO_0000034"}],"text":"ed and novel mAbs. A more mature appreciation of the immunobiology of individual FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” thera"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"19","span":{"begin":81,"end":85},"obj":"Gene"}],"attributes":[{"id":"A19","pred":"pubann:denotes","subj":"19","obj":"Gene:2213"}],"text":"ed and novel mAbs. A more mature appreciation of the immunobiology of individual FcγR function and the complexity of the relationships between FcγRs and antibodies is fueling efforts to develop more potent “next‐gen” thera"}